Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2007

Open Access 01-12-2007 | Research

Does measuring early basal serum follicular lutinising hormone assist in predicting In vitro fertilization (IVF)/Intracytoplasmic sperm injection (ICSI) outcome?

Authors: Ahmed Kassab, Luca Sabatini, Gidon Lieberman, Amanda Tozer, Ariel Zosmer, Colin Davis, Talha Al-Shawaf

Published in: Reproductive Biology and Endocrinology | Issue 1/2007

Login to get access

Abstract

Background

The aim was to examine the correlation of early follicular serum lutinising hormone (LH) and the clinical outcome of assisted reproduction technique (ART).

Methods

An observational study included 1333 consecutive women undergoing invitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). 964 women were having their first cycle of ART. Data were entered prospectively. All women had serum LH measured in the 6 months before the index cycle studied. No repeat cycles were included. The main outcomes measured were clinical pregnancy (CP) and live birth (LB) correlation to serum LH. Forward multivariate stepwise regression analysis was applied, and other statistical tests were used as appropriate.

Results

There was non significant correlation between basal serum LH and CP and LB in the polycystic ovary syndrome group (R2 = 0.02, F = 1.7 and P = 0.76) (R2 = 0.01, F = 2.6 and P = 0.77) respectively after adjusting for age, BMI, day of oocyte retrieval, starting dose, total dose of stimulation, type of gonadotrophin used, number of oocytes retrieved, fertilization rate and number of embryos transferred. Other aetiological causes group there was similarly non significant correlation between basal serum LH and CP (R2 = 0.05, F = 13.1 and P = 0.66), nor for LB (R2 = 0.007, F = 4.5 and P = 0.9).

Conclusion

Early follicular serum LH measurements in the 6 months before IVF/ICSI treatment cycle did not correlate with the clinical pregnancy or the live birth rate.
Appendix
Available only for authorised users
Literature
1.
go back to reference Meheshwari A, Fowler P, Bhattachrya S: Assesment of ovarian reserve-should we perform tests ovarian reserve routinely?. Hum Reprod. 2006, 21: 2729-2735. 10.1093/humrep/del188.CrossRef Meheshwari A, Fowler P, Bhattachrya S: Assesment of ovarian reserve-should we perform tests ovarian reserve routinely?. Hum Reprod. 2006, 21: 2729-2735. 10.1093/humrep/del188.CrossRef
2.
go back to reference Broekmans FJ, Kwee J, Hendricks DJ, Mol BW, Lambalk CB: A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006, 12: 685-718. 10.1093/humupd/dml034.CrossRefPubMed Broekmans FJ, Kwee J, Hendricks DJ, Mol BW, Lambalk CB: A systematic review of tests predicting ovarian reserve and IVF outcome. Hum Reprod Update. 2006, 12: 685-718. 10.1093/humupd/dml034.CrossRefPubMed
3.
go back to reference Johnson NP, Bagrie EM, Coomarasamy A, Bahattaacharya S, Shelling AN, Jessop S, Farquhar C, Khan KS: Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology. The International Systematic review of ovarian reserve test accuracy. BJOG. 2006, 113: 1472-1480. 10.1111/j.1471-0528.2006.01068.x.CrossRefPubMed Johnson NP, Bagrie EM, Coomarasamy A, Bahattaacharya S, Shelling AN, Jessop S, Farquhar C, Khan KS: Ovarian reserve tests for predicting fertility outcomes for assisted reproductive technology. The International Systematic review of ovarian reserve test accuracy. BJOG. 2006, 113: 1472-1480. 10.1111/j.1471-0528.2006.01068.x.CrossRefPubMed
4.
go back to reference Toporcerova S, Adam J, Toporcer T, Hredzak R, Ostro A: Basal concentrations of FSH (follicle stimulating hormone) as a predictor of success of IVF-ICSI cycle. Ceska Gynecol. 2006, 71: 474-479. Toporcerova S, Adam J, Toporcer T, Hredzak R, Ostro A: Basal concentrations of FSH (follicle stimulating hormone) as a predictor of success of IVF-ICSI cycle. Ceska Gynecol. 2006, 71: 474-479.
5.
go back to reference Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril. 1988, 50: 298-307.PubMed Muasher SJ, Oehninger S, Simonetti S, Matta J, Ellis LM, Liu HC, Jones GS, Rosenwaks Z: The value of basal and/or stimulated serum gonadotropin levels in prediction of stimulation response and in vitro fertilization outcome. Fertil Steril. 1988, 50: 298-307.PubMed
6.
go back to reference Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989, 51: 651-654.PubMed Scott RT, Toner JP, Muasher SJ, Oehninger S, Robinson S, Rosenwaks Z: Follicle stimulating hormone levels on cycle day 3 are predictive of in vitro fertilization outcome. Fertil Steril. 1989, 51: 651-654.PubMed
7.
go back to reference Toner JP, Philput CB, Jones GS, Muasher SJ: Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991, 55: 784-791.PubMed Toner JP, Philput CB, Jones GS, Muasher SJ: Basal follicle-stimulating hormone level is a better predictor of in vitro fertilization performance than age. Fertil Steril. 1991, 55: 784-791.PubMed
8.
go back to reference Meyer WR, Lavy G, Decherney AH, Visintin I, Economy K, Luborsky JL: Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990, 75: 795-799.PubMed Meyer WR, Lavy G, Decherney AH, Visintin I, Economy K, Luborsky JL: Evidence of gonadal and gonadotropin antibodies in women with a suboptimal ovarian response to exogenous gonadotropin. Obstet Gynecol. 1990, 75: 795-799.PubMed
9.
go back to reference National Collaboration Centre for Women's and Children's Health: Fertility assessment and treatment for people with fertility problems. NICE Clinical Guideline NO11. 2004, RCOG, 144- National Collaboration Centre for Women's and Children's Health: Fertility assessment and treatment for people with fertility problems. NICE Clinical Guideline NO11. 2004, RCOG, 144-
10.
go back to reference Rotterdam ESHRE/ASRM – Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19: 41-47. 10.1093/humrep/deh098.CrossRef Rotterdam ESHRE/ASRM – Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Hum Reprod. 2004, 19: 41-47. 10.1093/humrep/deh098.CrossRef
11.
go back to reference Rotterdam ESHRE/ASRM – Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004, 81 (1): 19-25. 10.1016/j.fertnstert.2003.10.004.CrossRef Rotterdam ESHRE/ASRM – Sponsored PCOS consensus workshop group: Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). Fertil Steril. 2004, 81 (1): 19-25. 10.1016/j.fertnstert.2003.10.004.CrossRef
12.
go back to reference Noci I, Biagiotti R, Maggi M, Ricci F, Cinotti A, Scarselli G: Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. Hum Reprod. 1998, 13: 531-534. 10.1093/humrep/13.3.531.CrossRefPubMed Noci I, Biagiotti R, Maggi M, Ricci F, Cinotti A, Scarselli G: Low day 3 luteinizing hormone values are predictive of reduced response to ovarian stimulation. Hum Reprod. 1998, 13: 531-534. 10.1093/humrep/13.3.531.CrossRefPubMed
13.
go back to reference Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M, Grunfeld L: An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril. 1996, 65: 588-593.PubMed Mukherjee T, Copperman AB, Lapinski R, Sandler B, Bustillo M, Grunfeld L: An elevated day three follicle-stimulating hormone:luteinizing hormone ratio (FSH:LH) in the presence of a normal day 3 FSH predicts a poor response to controlled ovarian hyperstimulation. Fertil Steril. 1996, 65: 588-593.PubMed
14.
go back to reference Barroso G, Oehninger S, Monzo A, Kolm P, Gibbons WE, Muasher SJ: High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J Assist Reprod Genet. 2001, 18: 499-505. 10.1023/A:1016601110424.PubMedCentralCrossRefPubMed Barroso G, Oehninger S, Monzo A, Kolm P, Gibbons WE, Muasher SJ: High FSH:LH ratio and low LH levels in basal cycle day 3: impact on follicular development and IVF outcome. J Assist Reprod Genet. 2001, 18: 499-505. 10.1023/A:1016601110424.PubMedCentralCrossRefPubMed
15.
go back to reference Jurema MW, Bracero NJ, Garcia JE: Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. Fertil Steril. 2003, 80: 1156-1161. 10.1016/S0015-0282(03)02159-9.CrossRefPubMed Jurema MW, Bracero NJ, Garcia JE: Fine tuning cycle day 3 hormonal assessment of ovarian reserve improves in vitro fertilization outcome in gonadotropin-releasing hormone antagonist cycles. Fertil Steril. 2003, 80: 1156-1161. 10.1016/S0015-0282(03)02159-9.CrossRefPubMed
16.
go back to reference Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ: Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril. 1995, 64: 1136-1140.PubMed Smotrich DB, Widra EA, Gindoff PR, Levy MJ, Hall JL, Stillman RJ: Prognostic value of day 3 estradiol on in vitro fertilization outcome. Fertil Steril. 1995, 64: 1136-1140.PubMed
17.
go back to reference Al-Inany H, Aboulghar M, Mansour R, Serour G: Meta-analysis of recombinant versus urinary-derived FSH: an update. Hum Reprod. 2003, 18: 305-313. 10.1093/humrep/deg088.CrossRefPubMed Al-Inany H, Aboulghar M, Mansour R, Serour G: Meta-analysis of recombinant versus urinary-derived FSH: an update. Hum Reprod. 2003, 18: 305-313. 10.1093/humrep/deg088.CrossRefPubMed
18.
go back to reference van Wely M, Westergaard LG, Bossuyt PM, van der Veen F: Human menopausal gonadotropin versus recombinant follicle stimulating hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2003, CD003973-1 van Wely M, Westergaard LG, Bossuyt PM, van der Veen F: Human menopausal gonadotropin versus recombinant follicle stimulating hormone for ovarian stimulation in assisted reproductive cycles. Cochrane Database Syst Rev. 2003, CD003973-1
19.
go back to reference Al-Shawaf T, Zosmer A, Hussain S, Tozer A, Panay N, Wilson C, Lower AM, Grudzinskas JG: Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients. Hum Reprod. 2001, 16: 24-30. 10.1093/humrep/16.1.24.CrossRefPubMed Al-Shawaf T, Zosmer A, Hussain S, Tozer A, Panay N, Wilson C, Lower AM, Grudzinskas JG: Prevention of severe ovarian hyperstimulation syndrome in IVF with or without ICSI and embryo transfer: a modified 'coasting' strategy based on ultrasound for identification of high-risk patients. Hum Reprod. 2001, 16: 24-30. 10.1093/humrep/16.1.24.CrossRefPubMed
20.
go back to reference Noci I, Maggi M, Fuzzi B, Biagiotti R, Ricci F, Marchionni M: Effect of low day 3 luteinizing hormone level on in vitro fertilization treatment outcome. Gynecol Endocrinol. 2000, 5: 321-326.CrossRef Noci I, Maggi M, Fuzzi B, Biagiotti R, Ricci F, Marchionni M: Effect of low day 3 luteinizing hormone level on in vitro fertilization treatment outcome. Gynecol Endocrinol. 2000, 5: 321-326.CrossRef
21.
go back to reference Meldrum DR, Tsao Z, Monroe SE, Braunstein GD, Sladek J, Lu JK, Vale W, Rivier J, Judd HL, Chang Rj: Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab. 1984, 58: 755-757.CrossRefPubMed Meldrum DR, Tsao Z, Monroe SE, Braunstein GD, Sladek J, Lu JK, Vale W, Rivier J, Judd HL, Chang Rj: Stimulation of LH fragments with reduced bioactivity following GnRH agonist administration in women. J Clin Endocrinol Metab. 1984, 58: 755-757.CrossRefPubMed
22.
go back to reference Loumaye E, Engrand P, Howles Cm, O'dea L: Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril. 1997, 67: 889-899. 10.1016/S0015-0282(97)81402-1.CrossRefPubMed Loumaye E, Engrand P, Howles Cm, O'dea L: Assessment of the role of serum luteinizing hormone and estradiol response to follicle-stimulating hormone on in vitro fertilization treatment outcome. Fertil Steril. 1997, 67: 889-899. 10.1016/S0015-0282(97)81402-1.CrossRefPubMed
23.
go back to reference Cabrera RA, Stadtmauer L, Mayer JF, Gibbons WE, Oehninger S: Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone. Fertil Steril. 2005, 83: 42-48. 10.1016/j.fertnstert.2004.06.050.CrossRefPubMed Cabrera RA, Stadtmauer L, Mayer JF, Gibbons WE, Oehninger S: Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone. Fertil Steril. 2005, 83: 42-48. 10.1016/j.fertnstert.2004.06.050.CrossRefPubMed
24.
go back to reference Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaua E, Devroey P: Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update. 2006, 12: 3-12. 10.1093/humupd/dmi030.CrossRefPubMed Kolibianakis EM, Collins J, Tarlatzis B, Papanikolaua E, Devroey P: Are endogenous LH levels during ovarian stimulation for IVF using GnRH analogues associated with the probability of ongoing pregnancy? A systematic review. Hum Reprod Update. 2006, 12: 3-12. 10.1093/humupd/dmi030.CrossRefPubMed
25.
go back to reference van Hooff MH, van der Meer M, Lambalk CB, Schoemaker J: Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome. Hum Reprod. 1999, 14: 1684-1689. 10.1093/humrep/14.7.1684.CrossRefPubMed van Hooff MH, van der Meer M, Lambalk CB, Schoemaker J: Variation of luteinizing hormone and androgens in oligomenorrhoea and its implications for the study of polycystic ovary syndrome. Hum Reprod. 1999, 14: 1684-1689. 10.1093/humrep/14.7.1684.CrossRefPubMed
26.
go back to reference Terriou P, Sapin C, Giorgetti C, Hans E, Spach JL, Roulier R: Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age. Fertil Steril. 2001, 75: 525-531. 10.1016/S0015-0282(00)01741-6.CrossRefPubMed Terriou P, Sapin C, Giorgetti C, Hans E, Spach JL, Roulier R: Embryo score is a better predictor of pregnancy than the number of transferred embryos or female age. Fertil Steril. 2001, 75: 525-531. 10.1016/S0015-0282(00)01741-6.CrossRefPubMed
27.
go back to reference van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, De Jong FH, Themmen AP: Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002, 17: 3065-3071. 10.1093/humrep/17.12.3065.CrossRefPubMed van Rooij IA, Broekmans FJ, te Velde ER, Fauser BC, Bancsi LF, De Jong FH, Themmen AP: Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve. Hum Reprod. 2002, 17: 3065-3071. 10.1093/humrep/17.12.3065.CrossRefPubMed
Metadata
Title
Does measuring early basal serum follicular lutinising hormone assist in predicting In vitro fertilization (IVF)/Intracytoplasmic sperm injection (ICSI) outcome?
Authors
Ahmed Kassab
Luca Sabatini
Gidon Lieberman
Amanda Tozer
Ariel Zosmer
Colin Davis
Talha Al-Shawaf
Publication date
01-12-2007
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2007
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/1477-7827-5-32

Other articles of this Issue 1/2007

Reproductive Biology and Endocrinology 1/2007 Go to the issue